Extracellular Vesicle-Mediated Delivery of microRNA-206 Antagomir Attenuates Lung Ischemia-Reperfusion Injury via Targeting Type II Epithelial Cell-Secreted CXCL1
Our hypothesis is that human adipose mesenchymal stem cell (MSC)-derived extracellular vesicle (EV) can be used as a delivery platform for microRNAs to effectively attenuate lung ischemia-reperfusion injury (IRI).
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: J. Cai, G. Su, V. Mas, A. Emtiazjoo, A. Pelaez, G.R. Upchurch, T. Machuca, A.K. Sharma Tags: (341) Source Type: research
More News: Cardiology | Heart | Heart Transplant | Lung Transplant | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants